Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 559
1.
J Agric Food Chem ; 72(18): 10531-10536, 2024 May 08.
Article En | MEDLINE | ID: mdl-38663860

In the past, taste interactions between sodium chloride (NaCl) and bitter tastants were investigated in human sensory studies, and the suppression of bitterness by sodium was observed. It is currently not clear if this phenomenon occurs predominantly peripherally or centrally and if the effect is general or only particular bitter compounds are blocked. Therefore, the influence of NaCl at the receptor level was tested by functional expression assays using four out of ∼25 human bitter taste receptors together with prototypical agonists. It was observed that NaCl affected only the responses of particular bitter taste receptor-compound pairs, whereas other bitter responses remained unchanged upon variations of the sodium concentrations. Among the tested receptors, TAS2R16 showed a reduction in signaling in the presence of NaCl. This demonstrates that for some receptor-agonist pairs, NaCl reduces the activation at the receptor level, whereas central effects may dominate the NaCl-induced bitter taste inhibition for other substances.


Receptors, G-Protein-Coupled , Sodium Chloride , Taste , Humans , Receptors, G-Protein-Coupled/metabolism , Receptors, G-Protein-Coupled/genetics , HEK293 Cells , Taste Buds/metabolism , Taste Buds/drug effects
2.
Nutrients ; 13(11)2021 Oct 23.
Article En | MEDLINE | ID: mdl-34836006

In addition to the taste receptors corresponding to the six basic taste qualities-sweet, salty, sour, bitter, umami, and fatty-another type of taste receptor, calcium-sensing receptor (CaSR), is found in taste-bud cells. CaSR is called the 'kokumi' receptor because its agonists increase sweet, salty and umami tastes to induce 'koku', a Japanese word meaning the enhancement of flavor characters such as thickness, mouthfulness, and continuity. Koku is an important factor for enhancing food palatability. However, it is not well known whether other kokumi-receptors and substances exist. Here, we show that ornithine (L-ornithine but not D-ornithine) at low concentrations that do not elicit a taste of its own, enhances preferences to sweet, salty, umami, and fat taste solutions in mice. Increased preference to monosodium glutamate (MSG) was the most dominant effect. Antagonists of G-protein-coupled receptor family C group 6 subtype A (GPRC6A) abolished the additive effect of ornithine on MSG solutions. The additive effects of ornithine on taste stimuli are thought to occur in the oral cavity, and are not considered post-oral events because ornithine's effects were confirmed in a brief-exposure test. Moreover, the additive effects of ornithine and the action of the antagonist were verified in electrophysiological taste nerve responses. Immunohistochemical analysis implied that GPRC6A was expressed in subsets of type II and type III taste cells of mouse circumvallate papillae. These results are in good agreement with those reported for taste modulation involving CaSR and its agonists. The present study suggests that ornithine is a kokumi substance and GPRC6A is a newly identified kokumi receptor.


Food Preferences/drug effects , Ornithine/pharmacology , Taste/physiology , Animals , Chorda Tympani Nerve/drug effects , Chorda Tympani Nerve/physiology , Male , Mice, Inbred C57BL , Physical Stimulation , Receptors, G-Protein-Coupled/antagonists & inhibitors , Receptors, G-Protein-Coupled/metabolism , Solutions , Taste/drug effects , Taste Buds/drug effects , Taste Buds/physiology
3.
Mol Pharmacol ; 99(5): 319-327, 2021 05.
Article En | MEDLINE | ID: mdl-33824185

Children have difficulty swallowing capsules. Yet, when presented with liquid formulations, children often reject oral medications due to their intense bitterness. Presently, effective strategies to identify methods, reagents, and tools to block bitterness remain elusive. For a specific bitter-tasting drug, identification of the responsible bitter receptors and discovery of antagonists for those receptors can provide a method to block perceived bitterness. We have identified a compound (6-methylflavone) that can block responses to an intensely bitter-tasting anti-human immunodeficiency virus (HIV) drug, tenofovir alafenamide (TAF), using a primary human taste bud epithelial cell culture as a screening platform. Specifically, TAS2R39 and TAS2R1 are the main type 2 taste receptors responding to TAF observed via heterologously expressing specific TAS2R receptors into HEK293 cells. In this assay, 6-methylflavone blocked the responses of TAS2R39 to TAF. In human sensory testing, 8 of 16 subjects showed reduction in perceived bitterness of TAF after pretreating (or "prerinsing") with 6-methylflavone and mixing 6-methylflavone with TAF. Bitterness was completely and reliably blocked in two of these subjects. These data demonstrate that a combined approach of human taste cell culture-based screening, receptor-specific assays, and human psychophysical testing can successfully discover molecules for blocking perceived bitterness of pharmaceuticals, such as the HIV therapeutic TAF. Our hope is to use bitter taste blockers to increase medical compliance with these vital medicines. SIGNIFICANCE STATEMENT: Identification of a small molecule that inhibits bitter taste from tenofovir alafenamide may increase the compliance in treating children with human immunodeficiency virus infections.


Adenine/analogs & derivatives , Flavoring Agents/administration & dosage , Flavoring Agents/chemistry , Taste Buds/drug effects , Taste/drug effects , Adenine/adverse effects , Adenine/chemistry , Adult , Alanine , Antiviral Agents/adverse effects , Antiviral Agents/chemistry , Cell Line , Female , Flavones/administration & dosage , Flavones/chemistry , HEK293 Cells , Humans , Male , Receptors, Cell Surface/metabolism , Receptors, G-Protein-Coupled/metabolism , Taste Buds/metabolism , Tenofovir/analogs & derivatives
4.
Am J Physiol Endocrinol Metab ; 320(3): E566-E580, 2021 03 01.
Article En | MEDLINE | ID: mdl-33427045

Sex as a biological variable has been the focus of increasing interest. Relatively few studies have focused, however, on differences in peripheral taste function between males and females. Nonetheless, there are reports of sex-dependent differences in chemosensitivity in the gustatory system. The involvement of endogenous changes in ovarian hormones has been suggested to account for taste discrepancies. Additionally, whether sex differences exist in taste receptor expression, activation, and subsequent signaling pathways that may contribute to different taste responsiveness is not well understood. In this study, we show the presence of both the nuclear and plasma membrane forms of estrogen receptor (ER) mRNA and protein in mouse taste cells. Furthermore, we provide evidence that estrogen increases taste cell activation during the application of fatty acids, the chemical cue for fat taste, in taste receptor cells. We found that genes important for the transduction pathway of fatty acids vary between males and females and that these differences also exist across the various taste papillae. In vivo support for the effect of estrogens in taste cells was provided by comparing the fatty acid responsiveness in male, intact female, and ovariectomized (OVX) female mice with and without hormone replacement. In general, females detected fatty acids at lower concentrations, and the presence of circulating estrogens increased this apparent fat taste sensitivity. Taken together, these data indicate that increased circulating estrogens in the taste system may play a significant role in physiology and chemosensory cellular activation and, in turn, may alter taste-driven behavior.NEW & NOTEWORTHY Using molecular, cellular, and behavioral analyses, this study shows that sex differences occur in fat taste in a mouse model. Female mice are more responsive to fatty acids, leading to an overall decrease in intake and fatty acid preference. These differences are linked to sex hormones, as estradiol enhances taste cell responsiveness to fatty acids during periods of low circulating estrogen following ovariectomy and in males. Estradiol is ineffective in altering fatty acid signaling during a high-estrogen period and in ovariectomized mice on hormone replacement. Thus, taste receptor cells are a direct target for actions of estrogen, and there are multiple receptors with differing patterns of expression in taste cells.


Dietary Fats/pharmacology , Estradiol/blood , Taste Buds/drug effects , Taste/physiology , Animals , Cells, Cultured , Dietary Fats/metabolism , Estrous Cycle/genetics , Estrous Cycle/metabolism , Female , Gene Expression Regulation/drug effects , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Ovariectomy , Receptors, Estrogen/genetics , Receptors, Estrogen/metabolism , Sex Characteristics , Taste/drug effects , Taste Buds/metabolism , Taste Perception/physiology
5.
Respir Res ; 22(1): 31, 2021 Jan 28.
Article En | MEDLINE | ID: mdl-33509163

BACKGROUND: Epithelial solitary chemosensory cell (tuft cell) bitter taste signal transduction occurs through G protein coupled receptors and calcium-dependent signaling pathways. Type II taste cells, which utilize the same bitter taste signal transduction pathways, may also utilize cyclic adenosine monophosphate (cAMP) as an independent signaling messenger in addition to calcium. METHODS: In this work we utilized specific pharmacologic inhibitors to interrogate the short circuit current (Isc) of polarized nasal epithelial cells mounted in Ussing chambers to assess the electrophysiologic changes associated with bitter agonist (denatonium) treatment. We also assessed release of human ß-defensin-2 from polarized nasal epithelial cultures following treatment with denatonium benzoate and/or potassium channel inhibitors. RESULTS: We demonstrate that the bitter taste receptor agonist, denatonium, decreases human respiratory epithelial two-pore potassium (K2P) current in polarized nasal epithelial cells mounted in Ussing chambers. Our data further suggest that this occurs via a cAMP-dependent signaling pathway. We also demonstrate that this decrease in potassium current lowers the threshold for denatonium to stimulate human ß-defensin-2 release. CONCLUSIONS: These data thus demonstrate that, in addition to taste transducing calcium-dependent signaling, bitter taste receptor agonists can also activate cAMP-dependent respiratory epithelial signaling pathways to modulate K2P currents. Bitter-agonist regulation of potassium currents may therefore serve as a means of rapid regional epithelial signaling, and further study of these pathways may provide new insights into regulation of mucosal ionic composition and innate mechanisms of epithelial defense.


Cyclic AMP/metabolism , Potassium Channels/metabolism , Quaternary Ammonium Compounds/pharmacology , Respiratory Mucosa/metabolism , Taste Buds/metabolism , Taste/physiology , Aversive Agents/pharmacology , Calcium Signaling/drug effects , Calcium Signaling/physiology , Humans , Nasal Mucosa/drug effects , Nasal Mucosa/metabolism , Respiratory Mucosa/drug effects , Signal Transduction/drug effects , Signal Transduction/physiology , Taste/drug effects , Taste Buds/drug effects
6.
J Neurochem ; 158(2): 233-245, 2021 07.
Article En | MEDLINE | ID: mdl-33319361

Leptin is known to selectively suppress neural and taste cell responses to sweet compounds. The sweet suppressive effect of leptin is mediated by the leptin receptor Ob-Rb, and the ATP-gated K+ (KATP ) channel expressed in some sweet-sensitive, taste receptor family 1 member 3 (T1R3)-positive taste cells. However, the intracellular transduction pathway connecting Ob-Rb to KATP channel remains unknown. Here we report that phosphoinositide 3-kinase (PI3K) mediates leptin's suppression of sweet responses in T1R3-positive taste cells. In in situ taste cell recording, systemically administrated leptin suppressed taste cell responses to sucrose in T1R3-positive taste cells. Such leptin's suppression of sucrose responses was impaired by co-administration of PI3K inhibitors (wortmannin or LY294002). In contrast, co-administration of signal transducer and activator of transcription 3 inhibitor (Stattic) or Src homology region 2 domain-containing phosphatase-2 inhibitor (SHP099) had no effect on leptin's suppression of sucrose responses, although signal transducer and activator of transcription 3 and Src homology region 2 domain-containing phosphatase-2 were expressed in T1R3-positive taste cells. In peeled tongue epithelium, phosphatidylinositol (3,4,5)-trisphosphate production and phosphorylation of AKT by leptin were immunohistochemically detected in some T1R3-positive taste cells but not in glutamate decarboxylase 67-positive taste cells. Leptin-induced phosphatidylinositol (3,4,5)-trisphosphate production was suppressed by LY294002. Thus, leptin suppresses sweet responses of T1R3-positive taste cells by activation of Ob-Rb-PI3K-KATP channel pathway.


Leptin/pharmacology , Phosphatidylinositol 3-Kinases/physiology , Receptors, G-Protein-Coupled/drug effects , Sweetening Agents/pharmacology , Taste Buds/drug effects , Taste/drug effects , Animals , Female , Male , Mice , Mice, Transgenic , Phosphatidylinositols/metabolism , Protein Kinase Inhibitors/pharmacology , STAT3 Transcription Factor/genetics , Signal Transduction/drug effects , Tongue/cytology , Tongue/drug effects
7.
J Neurosci ; 40(41): 7795-7810, 2020 10 07.
Article En | MEDLINE | ID: mdl-32878902

Mammalian taste buds are comprised of specialized neuroepithelial cells that act as sensors for molecules that provide nutrition (e.g., carbohydrates, amino acids, and salts) and those that are potentially harmful (e.g., certain plant compounds and strong acids). Type II and III taste bud cells (TBCs) detect molecules described by humans as "sweet," "bitter," "umami," and "sour." TBCs that detect metallic ions, described by humans as "salty," are undefined. Historically, type I glial-like TBCs have been thought to play a supportive role in the taste bud, but little research has been done to explore their role in taste transduction. Some evidence implies that type I cells may detect sodium (Na+) via an amiloride-sensitive mechanism, suggesting they play a role in Na+ taste transduction. We used an optogenetic approach to study type I TBCs by driving the expression of the light-sensitive channelrhodopsin-2 (ChR2) in type I GAD65+ TBCs of male and female mice. Optogenetic stimulation of GAD65+ TBCs increased chorda tympani nerve activity and activated gustatory neurons in the rostral nucleus tractus solitarius. "N neurons," whose NaCl responses were blocked by the amiloride analog benzamil, responded robustly to light stimulation of GAD65+ TBCs on the anterior tongue. Two-bottle preference tests were conducted under Na+-replete and Na+-deplete conditions to assess the behavioral impact of optogenetic stimulation of GAD65+ TBCs. Under Na+-deplete conditions GAD65-ChR2-EYFP mice displayed a robust preference for H2O illuminated with 470 nm light versus nonilluminated H2O, suggesting that type I glial-like TBCs are sufficient for driving a behavior that resembles Na+ appetite.SIGNIFICANCE STATEMENT This is the first investigation on the role of type I GAD65+ taste bud cells (TBCs) in taste-mediated physiology and behavior via optogenetics. It details the first definitive evidence that selective optogenetic stimulation of glial-like GAD65+ TBCs evokes neural activity and modulates behavior. Optogenetic stimulation of GAD65+ TBCs on the anterior tongue had the strongest effect on gustatory neurons that responded best to NaCl stimulation through a benzamil-sensitive mechanism. Na+-depleted mice showed robust preferences to "light taste" (H2O illuminated with 470 nm light vs nonilluminated H2O), suggesting that the activation of GAD65+ cells may generate a salt-taste sensation in the brain. Together, our results shed new light on the role of GAD65+ TBCs in gustatory transduction and taste-mediated behavior.


Appetite/physiology , Food Preferences/physiology , Glutamate Decarboxylase/physiology , Optogenetics/methods , Sensory Receptor Cells/physiology , Sodium/deficiency , Taste Buds/physiology , Amiloride/pharmacology , Animals , Appetite/drug effects , Channelrhodopsins , Cranial Nerves/physiology , Diuretics/pharmacology , Female , Food Preferences/drug effects , Glutamate Decarboxylase/drug effects , Male , Mice , Sensory Receptor Cells/drug effects , Sodium Chloride/pharmacology , Taste Buds/drug effects
8.
Nutrients ; 12(7)2020 Jul 07.
Article En | MEDLINE | ID: mdl-32645975

Taste buds containing receptor cells that primarily detect one taste quality provide the basis for discrimination across taste qualities. The molecular receptor multiplicity and the interactions occurring between bud cells encode information about the chemical identity, nutritional value, and potential toxicity of stimuli before transmitting signals to the hindbrain. PROP (6-n-propylthiouracil) tasting is widely considered a marker for individual variations of taste perception, dietary preferences, and health. However, controversial data have been reported. We present measures of the peripheral gustatory system activation in response to taste qualities by electrophysiological recordings from the tongue of 39 subjects classified for PROP taster status. The waveform of the potential variation evoked depended on the taste quality of the stimulus. Direct relationships between PROP sensitivity and electrophysiological responses to taste qualities were found. The largest and fastest responses were recorded in PROP super-tasters, who had the highest papilla density, whilst smaller and slower responses were found in medium tasters and non-tasters with lower papilla densities. The intensities perceived by subjects of the three taster groups correspond to their electrophysiological responses for all stimuli except NaCl. Our results show that each taste quality can generate its own electrophysiological fingerprint on the tongue and provide direct evidence of the relationship between general taste perception and PROP phenotype.


Propylthiouracil/pharmacology , Taste Buds/drug effects , Taste , Adult , Diet/methods , Electrophysiological Phenomena , Female , Humans , Male , Phenotype , Sodium Chloride/administration & dosage , Taste Perception/drug effects , Tongue/drug effects
9.
Biochem Pharmacol ; 178: 114086, 2020 08.
Article En | MEDLINE | ID: mdl-32522595

Polyphenols are phytochemical compounds found mostly in plants with several biological properties. Many of the benefits attributed to fruits and vegetables have been linked to their content in these molecules. As a result, the last decade has witnessed an increase in polyphenol-derived compounds claiming diverse therapeutic properties. Although the mechanism of action of such compounds is yet to be fully disclosed, one of the components that recently has been proposed to participate significantly in the health properties of polyphenols is the type 2 taste receptors (T2Rs). These receptors are responsible for the detection of bitter taste and represent the first line of defence against potentially harmful components in food. The recent discovery of extra-oral T2Rs in several metabolically active tissues has generated intense interest in the potential health impact. Given that most phenolic molecules taste bitter, exploring the T2Rs as a putative pharmacological target for the development of plant-based drug therapies is a promising field of research. Some T2Rs are involved in the control of cilia beat frequency and smooth muscle relaxation in the air tract together with leukocyte homeostasis, important events disrupted in the high prevalence of respiratory diseases. Furthermore, T2Rs are involved in nutrient-gut interactions to modulate gut hormones that influence gastrointestinal motility, appetite and glycemia. Thus, this commentary focuses on the latest novelty advances in relation to the peripheral expression of T2Rs, and polyphenols and T2Rs relationship from a therapeutic point of view.


Polyphenols/metabolism , Receptors, G-Protein-Coupled/metabolism , Taste Buds/metabolism , Taste/physiology , Animals , Gastrointestinal Tract/drug effects , Gastrointestinal Tract/metabolism , Humans , Polyphenols/administration & dosage , Taste/drug effects , Taste Buds/drug effects
10.
Tissue Cell ; 63: 101319, 2020 Apr.
Article En | MEDLINE | ID: mdl-32223947

Salivary epidermal growth factor (EGF) plays an important role in the maintenance of the oral and gastro-esophageal mucosa. Sialoadenectomy delays healing of oral wounds and affects lingual papillae. In this work, we aimed to determine the effect of EGF deficiency induced by sialoadenectomy and evaluate the effect of exogenous EGF administration on the lingual papillae and taste buds in rats. Thirty male adult Wistar albino rats were equally divided into 3 groups; sham-operated control group, sialoadenectomy group and group of sialoadenectomy + EGF. EGF was given 8 weeks after sialoadenectomy in a dose of 1 µg /ml/day in drinking water for 2 weeks. The anterior two-thirds of the tongue was dissected and cut longitudinally into two halves; one half for light microscope and the other for electron microscope examinations. Saliva and blood were collected to determine salivary and plasma EGF. Our results revealed that sialoadenectomy significantly reduced plasma and saliva levels of EGF which resulted in severe disruption of the architecture of lingual papillae. These changes were effectively improved by the exogenous EGF administration. In conclusion, EGF supplementation reversed the effects of sialoadenectomy and restored almost normal architecture of lingual papillae and taste buds.


Epidermal Growth Factor/metabolism , Salivary Glands/metabolism , Taste Buds/metabolism , Tongue/metabolism , Animals , Epidermal Growth Factor/deficiency , Epidermal Growth Factor/pharmacology , Esophageal Mucosa/drug effects , Esophageal Mucosa/metabolism , Humans , Mouth Mucosa/drug effects , Mouth Mucosa/metabolism , Rats , Saliva/drug effects , Saliva/metabolism , Salivary Glands/drug effects , Salivary Glands/surgery , Taste Buds/drug effects , Taste Buds/surgery , Tongue/drug effects , Tongue/pathology , Tongue/surgery
11.
Chem Senses ; 45(4): 249-259, 2020 05 21.
Article En | MEDLINE | ID: mdl-32154568

The chorda tympani (CT) nerve is exceptionally responsive to NaCl. Amiloride, an epithelial Na+ channel (ENaC) blocker, consistently and significantly decreases the NaCl responsiveness of the CT but not the glossopharyngeal (GL) nerve in the rat. Here, we examined whether amiloride would suppress the NaCl responsiveness of the CT when it cross-reinnervated the posterior tongue (PT). Whole-nerve electrophysiological recording was performed to investigate the response properties of the intact (CTsham), regenerated (CTr), and cross-regenerated (CT-PT) CT in male rats to NaCl mixed with and without amiloride and common taste stimuli. The intact (GLsham) and regenerated (GLr) GL were also examined. The CT responses of the CT-PT group did not differ from those of the GLr and GLsham groups, but did differ from those of the CTr and CTsham groups for some stimuli. Importantly, the responsiveness of the cross-regenerated CT to a series of NaCl concentrations was not suppressed by amiloride treatment, which significantly decreased the response to NaCl in the CTr and CTsham groups and had no effect in the GLr and GLsham groups. This suggests that the cross-regenerated CT adopts the taste response properties of the GL as opposed to those of the regenerated CT or intact CT. This work replicates the 5 decade-old findings of Oakley and importantly extends them by providing compelling evidence that the presence of functional ENaCs, essential for sodium taste recognition in regenerated taste receptor cells, depends on the reinnervated lingual region and not on the reinnervating gustatory nerve, at least in the rat.


Chorda Tympani Nerve/drug effects , Epithelial Sodium Channels/metabolism , Sodium Chloride/metabolism , Taste Buds/drug effects , Amiloride/metabolism , Amiloride/pharmacology , Animals , Dose-Response Relationship, Drug , Electrophysiology , Glossopharyngeal Nerve/metabolism , Male , Nerve Regeneration/drug effects , Rats , Rats, Sprague-Dawley , Stimulation, Chemical , Taste
12.
Chem Senses ; 45(3): 219-230, 2020 04 17.
Article En | MEDLINE | ID: mdl-32072157

The initial objective of this study was to determine if activation of the sweet taste receptor TAS1R2/TAS1R3 is necessary for perception of sweet thermal taste (swTT). Our approach was to inhibit the receptor with the inverse agonist lactisole using a temperature-controlled flow gustometer. Because all prior studies of thermal taste (TT) used metal thermodes to heat the tongue tip, we first investigated whether it could be generated in heated water. Experiment 1 showed that sweetness could be evoked when deionized water was heated from 20 to 35 °C, and testing with static temperatures between 20 and 35 °C demonstrated the importance of heating from a cool temperature. As in previous studies, thermal sweetness was reported by only a subset of participants, and replicate measurements found variability in reports of sweetness across trials and between sessions. Experiment 2 then showed that exposure to 8 mM lactisole blocked perception of swTT. Confirmation of the involvement of TAS1R2/TAS1R3 led to an investigation of possible sensory and cognitive interactions between thermal and chemical sweetness. Using sucrose as a sweet stimulus and quinine as a nonsweet control, we found that dynamic heating capable of producing thermal sweetness did not increase the sweetness of sucrose compared with static heating at 35 °C. However, swTT was disrupted if trials containing sucrose (but not quinine) were interspersed among heating-only trials. These findings provide new information relevant to understanding the perceptual processes and receptor mechanisms of swTT, as well as the heat sensitivity of sweet taste in general.


Benzene Derivatives/pharmacology , Receptors, G-Protein-Coupled/metabolism , Taste/drug effects , Temperature , Water/chemistry , Adolescent , Adult , Female , Humans , Male , Middle Aged , Receptors, G-Protein-Coupled/agonists , Sucrose/pharmacology , Sweetening Agents/pharmacology , Taste Buds/drug effects , Young Adult
13.
Appetite ; 145: 104499, 2020 02 01.
Article En | MEDLINE | ID: mdl-31669578

Sugar-sweetened beverages are the major source of added calories in the Western diet and their prevalence is associated with obesity and metabolic disruption. Despite the critical role of the taste system in determining food selection and consumption, the effects of chronic sucrose consumption on the peripheral taste system in mammals have received limited attention. We offered female Sprague Dawley rats free access to water and one of three diets for up to 40 days: (1) sucrose-free chow or "NS" diet; (2) a high-sucrose dry diet or "HS"; or (3) 30% sucrose solution and the NS diet, designated "LiqS" diet. Sucrose consumption by LiqS rats gradually increased and by day 14 was equal to that of HS rats. Food intake decreased in LiqS rats, but their energy intake remained higher than for NS or HS rats. There was no significant difference in weight gain of the groups during the study. Recordings from the chorda tympani nerve (CT), which innervates taste buds on the anterior tongue, revealed decreased responses to 1 M sucrose in both LiqS and HS rats and to acesulfame K and salt tastants in LiqS rats after 40 days on diet. Umami, bitter, and acid response magnitudes were unchanged in both groups. These results demonstrate that chronic sucrose exposure inhibits taste responses to higher concentrations of sweet stimuli. More surprisingly, CT responses to NaCl and 0.5M NaAc were significantly reduced in rats on the LiqS diet. Thus, the physical form of the diet influences taste responsiveness to salt and sweet taste function. These data suggest that taste buds are previously unappreciated targets of chronic sucrose consumption.


Dietary Sucrose/administration & dosage , Taste/drug effects , Animals , Chorda Tympani Nerve/drug effects , Chorda Tympani Nerve/physiology , Electrophysiological Phenomena , Energy Intake , Female , Food Preferences/drug effects , Rats , Rats, Sprague-Dawley , Solutions , Taste/genetics , Taste Buds/drug effects , Taste Buds/physiology , Weight Gain/drug effects
14.
Appetite ; 144: 104442, 2020 01 01.
Article En | MEDLINE | ID: mdl-31494153

Bitterness and astringency (dryness) are characteristic sensory attributes of flavanol-rich foods. The degree of polymerization (DP) of flavanols influences their bitter and astringent sensations. Smaller DP compounds can enter the papillae on the tongue, eliciting a bitter response. Larger DP compounds are sterically inhibited from entering papillae and instead interact with oral proteins, cause precipitation, and elicit astringent sensations. Previous research has indicated that bitterness preference is related to health status, density of fungiform papillae on the tongue, and sensitivity to bitter compounds such as 6-n-propyl-thiouracil (PROP). The purpose of this study was to examine trends in liking, bitterness intensity, and astringency intensity of wine-like products with flavanols of different DP using a consumer sensory panel. Participants (n = 102) were segmented by phenotypes: body fat percentage (BF%), body mass index (BMI), PROP sensitivity, and stated bitter food preference. Differences in wine liking, perceived bitterness intensity, and astringency intensity were observed between three model wine samples of varying flavanol mean degrees of polymerization (mDP, i.e. the average size (polymer length) of flavanol compounds in a mixture). Specifically, with increased mDP, overall liking and bitterness liking decreased, with concurrent increased perception of bitterness and astringency intensity. Greater differences between phenotypes were observed when participants were segmented by BF% and BMI classification, than when segmented by PROP sensitivity classification. Reduced ability to detect differences in bitterness and astringency were noted in participants of higher weight status. Overall, these data suggest that weight status in adults is a greater predictor of liking of flavanol-rich foods than bitterness sensitivity (as determined by PROP classification), and that reduced perception of bitterness and astringency associated with weight gain may impact selection and preference for these foods.


Body Composition/physiology , Food Preferences/drug effects , Polyphenols/administration & dosage , Taste/drug effects , Wine/analysis , Adipose Tissue , Adult , Body Mass Index , Body Weight/physiology , Female , Food Preferences/physiology , Humans , Male , Middle Aged , Polymerization , Propylthiouracil/administration & dosage , Taste/physiology , Taste Buds/drug effects , Taste Threshold/drug effects , Young Adult
15.
J Lipid Res ; 61(2): 133-142, 2020 02.
Article En | MEDLINE | ID: mdl-31806728

GPR120 is implicated as a lipid receptor in the oro-sensory detection of dietary fatty acids. However, the effects of GPR120 activation on dietary fat intake or obesity are not clearly understood. We investigated to determine whether the binding of TUG891, a novel GPR120 agonist, to lingual GPR120 modulates fat preference in mice. We explored the effects of TUG891 on obesity-related hormones and conducted behavioral choice tests on mice to better understand the physiologic relevance of the action of TUG891. In cultured mouse and human taste bud cells (TBCs), TUG891 induced a rapid increase in Ca2+ by acting on GPR120. A long-chain dietary fatty acid, linoleic acid (LA), also recruited Ca2+ via GPR120 in human and mouse TBCs. Both TUG891 and LA induced ERK1/2 phosphorylation and enhanced in vitro release of glucagon-like peptide-1 from cultured human and mouse TBCs. In situ application of TUG891 onto the tongue of anesthetized mice triggered the secretion of pancreatobiliary juice, probably via the tongue-brain-gut axis. Furthermore, lingual application of TUG891 altered circulating concentrations of cholecystokinin and adipokines, associated with decreased circulating LDL, in conscious mice. In behavioral tests, mice exhibited a spontaneous preference for solutions containing either TUG891 or LA instead of a control. However, addition of TUG891 to a solution containing LA significantly curtailed fatty acid preference. Our study demonstrates that TUG891 binds to lingual GPR120 receptors, activates the tongue-brain-gut axis, and modulates fat preference. These findings may support the development of new fat taste analogs that can change the approach to obesity prevention and treatment.


Biphenyl Compounds/pharmacology , Brain/drug effects , Gastrointestinal Microbiome/drug effects , Phenylpropionates/pharmacology , Receptors, G-Protein-Coupled/agonists , Taste Perception/drug effects , Tongue/drug effects , Animals , Brain/metabolism , Cells, Cultured , Humans , Male , Mice , Mice, Inbred C57BL , Receptors, G-Protein-Coupled/metabolism , Taste Buds/drug effects , Taste Buds/metabolism , Tongue/metabolism
16.
Cell ; 179(2): 392-402.e15, 2019 10 03.
Article En | MEDLINE | ID: mdl-31543264

The ability to sense sour provides an important sensory signal to prevent the ingestion of unripe, spoiled, or fermented foods. Taste and somatosensory receptors in the oral cavity trigger aversive behaviors in response to acid stimuli. Here, we show that the ion channel Otopetrin-1, a proton-selective channel normally involved in the sensation of gravity in the vestibular system, is essential for sour sensing in the taste system. We demonstrate that knockout of Otop1 eliminates acid responses from sour-sensing taste receptor cells (TRCs). In addition, we show that mice engineered to express otopetrin-1 in sweet TRCs have sweet cells that also respond to sour stimuli. Next, we genetically identified the taste ganglion neurons mediating each of the five basic taste qualities and demonstrate that sour taste uses its own dedicated labeled line from TRCs in the tongue to finely tuned taste neurons in the brain to trigger aversive behaviors.


Brain/physiology , Membrane Proteins/metabolism , Taste Buds/metabolism , Taste , Acids/pharmacology , Afferent Pathways/cytology , Afferent Pathways/metabolism , Afferent Pathways/physiology , Animals , Brain/cytology , Brain/metabolism , Female , Male , Membrane Proteins/genetics , Mice , Mice, Inbred C57BL , Taste Buds/drug effects , Taste Buds/physiology , Taste Perception
17.
Curr Opin Clin Nutr Metab Care ; 22(6): 472-478, 2019 11.
Article En | MEDLINE | ID: mdl-31490201

PURPOSE OF REVIEW: Polyphenols display beneficial health effects through chemopreventive actions on numerous chronic diseases including cancers, metabolic disorders, reproductive disorders and eating behaviour disorders. According to the principle of chemoreception, polyphenols bind cellular targets capable of accepting their stereochemistry, namely metabolizing enzymes and protein receptors, including taste receptors. The extraoral expression of taste receptors and their pharmacological interest in terms of novel drug therapies open up new perspectives on the potential use of these compounds and their interactions with other chemicals in cells. These new perspectives suggest the need to examine these phytochemicals further. However, most polyphenols have a bitterness property that may disrupt the acceptability of healthy foods or dietary supplements. RECENT FINDINGS: Polyphenols bind to oral and extraoral bitter type 2 taste receptors, which modulate the signalling pathways involved in anti-inflammatory processes and metabolic and dietary regulations. Depending on their chemical nature, polyphenols may act as activators or inhibitors of taste receptors, and combinations of polyphenols (or herbal mixtures) may be used to modulate the acceptability of bitterness. SUMMARY: The current review summarizes recent findings on polyphenol chemoreception and highlights the evidence of healthy effects through type 2 taste receptor mediation in signalling pathways, such as new targets, with promising perspectives.


Phytochemicals , Polyphenols , Taste Buds , Humans , Signal Transduction , Taste/physiology , Taste Buds/drug effects , Taste Buds/physiology
18.
Sci Rep ; 9(1): 9759, 2019 07 05.
Article En | MEDLINE | ID: mdl-31278319

Fungiform papillae house taste buds on the anterior dorsal tongue. Literature is inconclusive as to whether taste perception correlates with fungiform papillae density (FPD). Gustatory reflexes modulate the amount and composition of saliva subsequently produced, and thus may be a more physiologically objective measure of tastant-receptor interactions. Taste perception fluctuates with time but the stability of individual fungiform papillae is unclear. This study followed ten healthy volunteers longitudinally at baseline, one and six months. FPD, diameter and position were measured and participants rated intensity perception of sucrose, caffeine, menthol and capsaicin solutions. Salivary flow rate, protein concentration and relative changes in protein composition were measured following each tastant. FPD, diameter and position were unchanged at six months. FPD did not correlate with intensity rating for any taste. FPD did correlate with changes in salivary protein output following sucrose (ρ = 0.72, p = 0.02) and changes in levels of proline-rich protein and mucin 7 following capsaicin (ρ = 0.71, p = 0.02, ρ = 0.68, p = 0.04, respectively). These results suggest that over six months fungiform papillae are anatomically stable, playing a greater role in mediating the physiological salivary response to stimuli rather than determining the perceived intensity of taste.


Saliva/metabolism , Taste Buds/anatomy & histology , Taste Buds/physiology , Taste Perception/physiology , Adult , Capsaicin/pharmacology , Female , Humans , Male , Menthol/pharmacology , Salivary Proteins and Peptides/biosynthesis , Sucrose/pharmacology , Taste Buds/drug effects , Young Adult
19.
J Neurosci ; 39(32): 6224-6232, 2019 08 07.
Article En | MEDLINE | ID: mdl-31171579

How taste buds detect NaCl remains poorly understood. Among other problems, applying taste-relevant concentrations of NaCl (50-500 mm) onto isolated taste buds or cells exposes them to unphysiological (hypo/hypertonic) conditions. To overcome these limitations, we used the anterior tongue of male and female mice to implement a slice preparation in which fungiform taste buds are in a relatively intact tissue environment and stimuli are limited to the taste pore. Taste-evoked responses were monitored using confocal Ca2+ imaging via GCaMP3 expressed in Type 2 and Type 3 taste bud cells. NaCl evoked intracellular mobilization of Ca2+ in the apical tips of a subset of taste cells. The concentration dependence and rapid adaptation of NaCl-evoked cellular responses closely resembled behavioral and afferent nerve responses to NaCl. Importantly, taste cell responses were not inhibited by the diuretic, amiloride. Post hoc immunostaining revealed that >80% of NaCl-responsive taste bud cells were of Type 2. Many NaCl-responsive cells were also sensitive to stimuli that activate Type 2 cells but never to stimuli for Type 3 cells. Ion substitutions revealed that amiloride-insensitive NaCl responses depended on Cl- rather than Na+ Moreover, choline chloride, an established salt taste enhancer, was equally effective a stimulus as sodium chloride. Although the apical transducer for Cl- remains unknown, blocking known chloride channels and cotransporters had little effect on NaCl responses. Together, our data suggest that chloride, an essential nutrient, is a key determinant of taste transduction for amiloride-insensitive salt taste.SIGNIFICANCE STATEMENT Sodium and chloride are essential nutrients and must be regularly consumed to replace excreted NaCl. Thus, understanding salt taste, which informs salt appetite, is important from a fundamental sensory perspective and forms the basis for interventions to replace/reduce excess Na+ consumption. This study examines responses to NaCl in a semi-intact preparation of mouse taste buds. We identify taste cells that respond to NaCl in the presence of amiloride, which is significant because much of human salt taste also is amiloride-insensitive. Further, we demonstrate that Cl-, not Na+, generates these amiloride-insensitive salt taste responses. Intriguingly, choline chloride, a commercial salt taste enhancer, is also a highly effective stimulus for these cells.


Chlorides/pharmacology , Flavoring Agents/pharmacology , Sodium Chloride/pharmacology , Taste Buds/physiology , Taste/physiology , Amiloride/pharmacology , Animals , Anions/pharmacology , Calcium Signaling/drug effects , Choline/pharmacology , Female , Ion Channels/drug effects , Ion Channels/physiology , Male , Mice , Nucleotides, Cyclic/analysis , Saccharin/pharmacology , Taste Buds/drug effects
20.
PLoS One ; 14(4): e0214890, 2019.
Article En | MEDLINE | ID: mdl-30947285

Chemotherapy often causes side effects that include disturbances in taste functions. Cyclophosphamide (CYP) is a chemotherapy drug that, after a single dose, elevates murine taste thresholds at times related to drug-induced losses of taste sensory cells and disruptions of proliferating cells that renew taste sensory cells. Pretreatment with amifostine can protect the taste system from many of these effects. This study compared the effects of a single dose (75 mg/kg) of CYP with effects generated by fractionated dosing of CYP (5 doses of 15 mg/kg), a dosing approach often used during chemotherapy, on the taste system of mice using immunohistochemistry. Dose fractionation prolonged the suppressive effects of CYP on cell proliferation responsible for renewal of taste sensory cells. Fractionation also reduced the total number of cells and the proportion of Type II cells within taste buds. The post-injection time of these losses coincided with the life span of Type I and II taste cells combined with lack of replacement cells. Fractionated dosing also decreased Type III cells more than a single dose, but loss of these cells may be due to factors related to the general health and/or cell renewal of taste buds rather than the life span of Type III cells. In general, pretreatment with amifostine appeared to protect taste cell renewal and the population of cells within taste buds from the cytotoxic effects of CYP with few observable adverse effects due to repeated administration. These findings may have important implications for patients undergoing chemotherapy.


Amifostine/pharmacology , Cyclophosphamide/adverse effects , Taste Buds/drug effects , Taste/drug effects , Animals , Antineoplastic Agents/administration & dosage , Antineoplastic Agents/adverse effects , Cell Count , Cell Proliferation/drug effects , Cyclophosphamide/administration & dosage , Cyclophosphamide/antagonists & inhibitors , Dose-Response Relationship, Drug , Humans , Immunohistochemistry , Male , Mice , Mice, Inbred C57BL , Phospholipase C beta/metabolism , Protective Agents/pharmacology , Synaptosomal-Associated Protein 25/metabolism , Taste Buds/metabolism , Taste Buds/pathology
...